Aileron Therapeutics, Inc. ("Aileron") (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of ...

Korea.net reporters and Seoul-based correspondents for 10 foreign media outlets including The Yomiuri Shimbun and Jiji Press ...

Aileron Therapeutics' Phase 1b trial shows LTI-03 improved biomarkers and reduced SPD levels, indicating the potential to ...

(RTTNews) - Aileron Therapeutics, Inc. (ALRN), Wednesday announced positive topline data from the cohort 2 of Phase 1b study evaluating LTI-03 in patients with idiopathic pulmonary fibrosis (IPF).

High-dose LTI-03 (5 mg BID), a Caveolin-1 related peptide, reduced expression of multiple profibrotic proteins in both ...

Billionaire Bruce Mathieson has lashed out at the board and management of embattled pubs and bottle shops giant Endeavour ...

Aileron Therapeutics (ALRN) announced positive topline data from Cohort 2 of its Phase 1b clinical trial evaluating the safety and tolerability ...

"The Literature Translation Institute (LTI) of Korea strives to make a big leap as a bridgehead to globally promote the depth ...

EPAM, which follows a January-December fiscal year, closed the September quarter with $1.17 billion in revenue, achieving a ...

Discussions on supporting Korean literature are gaining momentum following Han Kang’s Nobel Prize in Literature. On Nov. 11, ...

Discover which luxury hotel brands have come out on top in 2024 in the annual ranking by Luxury Travel Intelligence (LTI).

Chon Soo-yong, the newly appointed president of the Literature Translation Institute of Korea (LTI Korea), vowed to take ...